Organogenesis Holdings Inc (ORGO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Organogenesis Holdings Inc Stock (ORGO) Company Profile

Organogenesis Holdings Inc

Healthcare (1117)

781-575-0775

85 DAN ROAD, CANTON, MA

Nächster Verdiensttermin

Neueste SEC-Einreichungen

ORGO's Discussions on Twitter

Vergleichen Sie ORGO mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ORGO Organogenesis Holdings Inc	4.115	534.30M	433.14M	4.95M	6.55M	0.0357
ZTS Zoetis Inc	126.26	55.90B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	16.33	51.72B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.91	44.71B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	32.03	37.30B	16.88B	666.71M	251.19M	0.6132
RGC Regencell Bioscience Holdings Ltd	50.10	20.48B	0	-5.87M	-767.30K	-0.45

Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-06-28	Eingeleitet	Lake Street	Buy
2024-02-07	Eingeleitet	Cantor Fitzgerald	Overweight
2023-06-15	Eingeleitet	Morgan Stanley	Equal-Weight
2023-05-24	Hochstufung	BTIG Research	Neutral → Buy
2022-11-10	Herabstufung	BTIG Research	Buy → Neutral
2022-08-10	Herabstufung	Oppenheimer	Outperform → Perform
2020-01-10	Eingeleitet	SVB Leerink	Outperform
2019-08-26	Fortgesetzt	Credit Suisse	Outperform
2019-05-02	Eingeleitet	Credit Suisse	Outperform
2019-04-17	Eingeleitet	Oppenheimer	Outperform
2019-04-11	Eingeleitet	SunTrust	Buy

Alle ansehen

Organogenesis Holdings Inc Aktie (ORGO) Neueste Nachrichten

Finanzdaten der Organogenesis Holdings Inc-Aktie (ORGO)

Organogenesis Holdings Inc (ORGO)

Organogenesis Holdings Inc Stock (ORGO) Company Profile

Vergleichen Sie ORGO mit anderen Aktien

Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades

Organogenesis Holdings Inc Aktie (ORGO) Neueste Nachrichten

Is Organogenesis Holdings Inc. (2PQ) stock protected from inflationEarnings Overview Summary & Expert Curated Trade Setup Alerts - ulpravda.ru

Is Organogenesis Holdings Inc. stock a buy in volatile markets2025 Top Decliners & Growth Oriented Trade Recommendations - ulpravda.ru

What margin trends mean for Organogenesis Holdings Inc. stockIPO Watch & Pattern Based Trade Signal System - ulpravda.ru

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - PR Newswire

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis ... - Bluefield Daily Telegraph

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc.ORGO - FinancialContent

Three rising investors just landed bigger roles at a healthcare PE firm - Stock Titan

Organogenesis (NASDAQ:ORGO) Shares Down 5%Here's What Happened - MarketBeat

Organogenesis drops as Medicare to pull skin substitute LCDs (update) - MSN

Organogenesis Holdings extends leases for Canton facilities through 2032 By Investing.com - Investing.com Australia

Organogenesis Holdings extends leases for Canton facilities through 2032 - Investing.com

Organogenesis Extends Long-Term Leases for Key Facilities - TipRanks

Organogenesis (NASDAQ:ORGO) Shares Gap DownTime to Sell? - MarketBeat

Organogenesis' (ORGO) "Buy" Rating Reiterated at BTIG Research - MarketBeat

Organogenesis stock holds Buy rating at BTIG after CMS LCD decision - Investing.com Australia

Organogenesis stock holds Buy rating at BTIG after CMS LCD decision By Investing.com - Investing.com South Africa

Organogenesis Announces Initiation of Biologics License Application for ReNu® - The Manila Times

Organogenesis Initiates BLA Submission For ReNu In Knee Arthritis - Nasdaq

Organogenesis begins FDA rolling review for knee arthritis treatment By Investing.com - Investing.com Nigeria

Organogenesis starts rolling submission for ReNu allograft for knee arthritis - Seeking Alpha

Organogenesis stock rises after initiating FDA application for knee arthritis treatment By Investing.com - Investing.com South Africa

Organogenesis stock rises after initiating FDA application for knee arthritis treatment - Investing.com Nigeria

Organogenesis begins FDA rolling review for knee arthritis treatment - Investing.com

Organogenesis Holdings Inc. Initiates Biologics License Application for ReNu® to Address Knee Osteoarthritis Pain - Quiver Quantitative

Biologic treatment for knee arthritis pain begins FDA license bid - Stock Titan

Gains Recap: Is Organogenesis Holdings Inc stock dividend yield sustainableWeekly Gains Report & Fast Gaining Stock Strategy Reports - moha.gov.vn

Net current asset value per share of Organogenesis Holdings, Inc. Class A – BER:2PQ - TradingView — Track All Markets

BTIG reiterates Organogenesis Holdings (ORGO) buy recommendation - MSN

Is Organogenesis Holdings Inc. stock a bargain at current levels2025 Momentum Check & Advanced Technical Analysis Signals - Улправда

Assenagon Asset Management S.A. Has $20.49 Million Stock Position in Organogenesis $ORGO - MarketBeat

Organogenesis (NASDAQ:ORGO) Shares Down 3.7% on Insider Selling - MarketBeat

Organogenesis Holdings Inc. (ORGO) Stock Analysis: 47% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews

Is Organogenesis Holdings Inc. stock dividend yield sustainableJuly 2025 Outlook & Breakout Confirmation Trade Signals - DonanımHaber

Is Organogenesis Holdings Inc. stock supported by strong cash flows2025 Price Targets & Free Safe Capital Growth Stock Tips - Улправда

Organogenesis (NASDAQ:ORGO) Director Glenn Nussdorf Sells 200,000 Shares - MarketBeat

Organogenesis Holdings Insider Sold Shares Worth $1,027,060, According to a Recent SEC Filing - marketscreener.com

Organogenesis Holdings Inc. (ORGO) director sells 200,000 shares - Stock Titan

How Organogenesis Holdings Inc. stock benefits from global expansion2025 Big Picture & Low Risk High Win Rate Stock Picks - Улправда

Organogenesis (NASDAQ:ORGO) Trading Up 8.5%Here's What Happened - MarketBeat

How Organogenesis Holdings Inc. stock reacts to oil pricesBreakout Watch & Consistent Return Strategy Ideas - Улправда

Recent Analysts’ Ratings Updates for Organogenesis (ORGO) - Defense World

Organogenesis (NASDAQ:ORGO) Earns “Buy” Rating from BTIG Research - Defense World

Organogenesis (NASDAQ:ORGO) Shares Gap UpTime to Buy? - MarketBeat

BTIG Research Reaffirms Buy Rating for Organogenesis (NASDAQ:ORGO) - MarketBeat

Organogenesis Plans to File Biologics Licenses Application for Knee Osteoarthritis Pain Therapy by 2025-End, Shares Up Pre-Bell - marketscreener.com

Organogenesis To File Rolling BLA For ReNu Following FDA Meeting - Nasdaq

Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain - The Manila Times

Organogenesis stock soars after FDA meeting clears path for ReNu BLA - Investing.com Nigeria

Organogenesis to submit rolling BLA for knee osteoarthritis treatment - Investing.com India

Finanzdaten der Organogenesis Holdings Inc-Aktie (ORGO)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie ORGO